Free Trial

Teva Pharmaceutical Industries (TEVA) SEC Filings & 10K Form

Teva Pharmaceutical Industries logo
$18.66 -0.24 (-1.24%)
As of 03:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Teva Pharmaceutical Industries SEC Filings

DateFilerForm TypeView
08/06/2025
11:14 AM
FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SCHEDULE 13G/A
08/01/2025
3:01 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
3:04 PM
Jover Placid (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2025
6:06 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2025
8:25 AM
Phoenix Financial Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SCHEDULE 13G
07/17/2025
10:57 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SCHEDULE 13G
06/09/2025
3:15 PM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:18 PM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:20 PM
Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:22 PM
Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:25 PM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:52 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
3:16 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
4:13 PM
Teva Pharmaceutical Industries (Subject)
Form FWP
05/19/2025
5:50 AM
Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form 424B5
05/08/2025
1:34 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
04/07/2025
3:01 PM
Lippman Evan (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2025
3:22 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:25 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:29 PM
Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:08 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:11 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:13 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:14 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
03/04/2025
5:57 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:30 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:37 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:44 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:07 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:59 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:14 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
10:52 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
11:38 AM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
7:06 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:03 PM
BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:04 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
10:39 AM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G
11/06/2024
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:TEVA) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners